首页> 外文期刊>Natural product communications >Dissecting Traditional Chinese Medicines by Omics and Bioinformatics
【24h】

Dissecting Traditional Chinese Medicines by Omics and Bioinformatics

机译:通过组学和生物信息学解剖中药

获取原文
获取原文并翻译 | 示例
           

摘要

Traditional Chinese medicines (TCM) are a rich source of potential leads for drug development. However, there are fundamental differences between traditional Chinese medical concepts and modern pharmacology, which greatly hinder the modern development of TCM. To address this challenge, new techniques associated with genomics, transcriptomics, proteomics, metabolomics and bioinformatics have been used to dissect the pharmacological mechanisms of TCM. This review article provides an overview of the current research in this area, and illustrates the potential of omic and bioinformatic methods in TCM-based drug discovery.
机译:中药(TCM)是潜在的药物开发潜在来源。但是,中医观念与现代药理学之间存在根本差异,极大地阻碍了中医药的现代化发展。为了应对这一挑战,与基因组学,转录组学,蛋白质组学,代谢组学和生物信息学相关的新技术已被用于剖析中药的药理机制。这篇综述文章概述了该领域的最新研究,并说明了在基于中医的药物发现中眼科和生物信息学方法的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号